Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Warren

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Experimental Cell Research|February 1, 1981
Metabolic cooperation in CHO and V79 cells following treatment with a tumor promoterS T Warren, L P Yotti, J R Moskal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1981
Elevated spontaneous mutation rate in Bloom syndrome fibroblastsS T Warren, R A Schultz, C C Chang, et al.
Carcinogenesis|January 1, 1982
Evaluation of the carcinogenic potential of 2,4-dinitrofluorobenzene and its implications regarding mutagenicity testingS T Warren, D J Doolittle, C C Chang, et al.
Molecular Cell|July 11, 1998
FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this associationY Feng, D Absher, D E Eberhart, et al.
American Journal of Diseases of Children (1960)|June 1, 1981
Familial occurrence of congenital pulmonary lymphangiectasis. Genetic implicationsA B Scott-Emuakpor, S T Warren, S Kapur, et al.
Human Molecular Genetics|April 18, 2000
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical featuresA M Peier, K L McIlwain, A Kenneson, et al.
The Journal of Biological Chemistry|June 23, 1998
Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation proteinV Brown, K Small, L Lakkis, et al.
Neuroscience|December 29, 1999
Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala functionW Paradee, H E Melikian, D L Rasmussen, et al.
The Journal of Biological Chemistry|January 15, 2000
Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factorD Ping, G Boekhoudt, F Zhang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 1, 1997
Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomesY Feng, C A Gutekunst, D E Eberhart, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Experimental Cell Research|February 1, 1981
Metabolic cooperation in CHO and V79 cells following treatment with a tumor promoterS T Warren, L P Yotti, J R Moskal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1981
Elevated spontaneous mutation rate in Bloom syndrome fibroblastsS T Warren, R A Schultz, C C Chang, et al.
Carcinogenesis|January 1, 1982
Evaluation of the carcinogenic potential of 2,4-dinitrofluorobenzene and its implications regarding mutagenicity testingS T Warren, D J Doolittle, C C Chang, et al.
Molecular Cell|July 11, 1998
FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this associationY Feng, D Absher, D E Eberhart, et al.
American Journal of Diseases of Children (1960)|June 1, 1981
Familial occurrence of congenital pulmonary lymphangiectasis. Genetic implicationsA B Scott-Emuakpor, S T Warren, S Kapur, et al.
Human Molecular Genetics|April 18, 2000
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical featuresA M Peier, K L McIlwain, A Kenneson, et al.
The Journal of Biological Chemistry|June 23, 1998
Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation proteinV Brown, K Small, L Lakkis, et al.
Neuroscience|December 29, 1999
Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala functionW Paradee, H E Melikian, D L Rasmussen, et al.
The Journal of Biological Chemistry|January 15, 2000
Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factorD Ping, G Boekhoudt, F Zhang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 1, 1997
Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomesY Feng, C A Gutekunst, D E Eberhart, et al.
Pageof 11